Detalhe da pesquisa
1.
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma.
N Engl J Med;
2024 Jun 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38828984
2.
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
N Engl J Med;
387(23): 2113-2125, 2022 12 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36477031
3.
Avelumab treatment for patients with metastatic Merkel cell carcinoma can be safely stopped after 1 year and a PET/CT-confirmed complete response.
Cancer;
130(3): 433-438, 2024 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37788133
4.
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
BMC Cancer;
23(1): 648, 2023 Jul 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37434119
5.
Cytoreductive nephrectomy and exposure to sunitinib - a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME) trial.
BJU Int;
130(1): 68-75, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34706141
6.
Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single-arm, Open-label Phase II Trial.
Ann Surg;
274(2): 383-389, 2021 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33843797
7.
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Lancet Oncol;
20(7): 948-960, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31160251
8.
The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib/II randomized double-blind placebo-controlled trial (NivoILP trial).
Eur J Surg Oncol;
50(6): 108265, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38493679
9.
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600mutated melanoma.
Clin Cancer Res;
2024 May 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38739109
10.
Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?
Eur Urol Open Sci;
55: 15-22, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37693729
11.
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.
J Clin Oncol;
41(3): 528-540, 2023 01 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35998300
12.
IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation.
J Immunother Cancer;
11(7)2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37479483
13.
Diagnostic performance of early increase in S100B or LDH as outcome predictor for non-responsiveness to anti-PD-1 monotherapy in advanced melanoma.
Clin Chim Acta;
533: 71-78, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35709988
14.
Primary Renal Tumour Response in Patients Treated with Nivolumab and Ipilimumab for Metastatic Renal Cell Carcinoma: Real-world Data Assessment.
Eur Urol Open Sci;
35: 54-58, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35024632
15.
Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges.
Clin Transl Radiat Oncol;
33: 93-98, 2022 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35243019
16.
Switch to checkpoint inhibition after targeted therapy at time of progression or during ongoing response: A retrospective single-centre experience in patients with BRAF-mutated melanoma.
Pigment Cell Melanoma Res;
33(3): 498-506, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31646741
17.
Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II).
Melanoma Res;
30(3): 261-267, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31895752
18.
Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM).
Melanoma Res;
30(3): 252-260, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31895753
19.
Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2.
Cardiovasc Res;
78(1): 175-84, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18192240
20.
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial.
JAMA Oncol;
5(2): 164-170, 2019 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30543350